loadpatents
name:-0.050624132156372
name:-0.046344995498657
name:-0.022168874740601
Koike; Tatsuki Patent Filings

Koike; Tatsuki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Koike; Tatsuki.The latest application filed is for "heterocyclic compound".

Company Profile
20.40.47
  • Koike; Tatsuki - Kanagawa JP
  • KOIKE; Tatsuki - Fujisawa-shi Kanagawa
  • Koike; Tatsuki - Fujisawa JP
  • KOIKE; Tatsuki - Osaka-shi JP
  • Koike; Tatsuki - Osaka JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heterocyclic compound and use thereof
Grant 11,440,883 - Kajita , et al. September 13, 2
2022-09-13
Heterocyclic compound and application thereof
Grant 11,319,286 - Fujimoto , et al. May 3, 2
2022-05-03
Heterocyclic Compound
App 20220017514 - KAJITA; Yuichi ;   et al.
2022-01-20
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 11,174,272 - Koike , et al. November 16, 2
2021-11-16
Heterocyclic Compound And Use Thereof
App 20210276949 - HATTORI; Yasushi ;   et al.
2021-09-09
Heterocyclic Compound And Application Thereof
App 20210269420 - FUJIMOTO; Tatsuhiko ;   et al.
2021-09-02
Substituted pyrrolidine compound and use thereof
Grant 11,059,780 - Daini , et al. July 13, 2
2021-07-13
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20210206781 - KOIKE; Tatsuki ;   et al.
2021-07-08
Heterocyclic Compound And Use Thereof
App 20210198240 - ODA; Tsuneo ;   et al.
2021-07-01
Substituted pyrrolidine compound and use thereof
Grant 11,034,700 - Mikami , et al. June 15, 2
2021-06-15
Heterocyclic compound and use thereof
Grant 11,028,048 - Hattori , et al. June 8, 2
2021-06-08
Substituted Pyrrolidine Compound And Use Thereof
App 20200392149 - MIKAMI; Satoshi ;   et al.
2020-12-17
Document Creation Assistance Server And Document Creation Assistance Method
App 20200388354 - NARA; Hiroshi ;   et al.
2020-12-10
Substituted Pyrrolidine Compound And Use Thereof
App 20200385345 - DAINI; Masaki ;   et al.
2020-12-10
Heterocyclic Compound And Application Thereof
App 20200385346 - FUJIMOTO; Tatsuhiko ;   et al.
2020-12-10
Heterocyclic Compound And Use Thereof
App 20200247747 - Kind Code
2020-08-06
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 10,717,748 - Koike , et al.
2020-07-21
Heterocyclic Compound And Use Thereof
App 20200207715 - Kajita; Yuichi ;   et al.
2020-07-02
Heterocyclic Compound And Use Thereof
App 20200207734 - KAJITA; Yuichi ;   et al.
2020-07-02
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20200157117 - KOIKE; Tatsuki ;   et al.
2020-05-21
Heterocyclic compound and use thereof
Grant 10,584,097 - Kajita , et al.
2020-03-10
Aromatic ring compound
Grant 10,548,877 - Ogino , et al. Fe
2020-02-04
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 10,550,129 - Koike , et al. Fe
2020-02-04
Heterocyclic Compound And Use Thereof
App 20200017444 - KAJITA; Yuichi ;   et al.
2020-01-16
Heterocyclic compound and use thereof
Grant 10,428,023 - Kajita , et al. October 1, 2
2019-10-01
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20190233436 - KOIKE; Tatsuki ;   et al.
2019-08-01
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 10,273,245 - Koike , et al.
2019-04-30
Aromatic Ring Compound
App 20190083467 - OGINO; Masaki ;   et al.
2019-03-21
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20190071455 - KOIKE; Tatsuki ;   et al.
2019-03-07
Heterocyclic compound
Grant 10,202,376 - Kimura , et al. Feb
2019-02-12
Heterocyclic Compound And Use Thereof
App 20190040010 - Kajita; Yuichi ;   et al.
2019-02-07
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 10,144,743 - Koike , et al. De
2018-12-04
Heterocyclic compounds having cholesterol 24-hydroxylase activity
Grant 10,112,956 - Koike , et al. October 30, 2
2018-10-30
Heterocyclic compound
Grant 10,106,556 - Ikeda , et al. October 23, 2
2018-10-23
Radiolabeled compounds
Grant 9,963,443 - Koike , et al. May 8, 2
2018-05-08
Heterocyclic Compound
App 20180079756 - IKEDA; Shuhei ;   et al.
2018-03-22
Heterocyclic Compound
App 20170362223 - KIMURA; Eiji ;   et al.
2017-12-21
Heterocyclic Compounds Having Cholesterol 24-hydroxylase Activity
App 20170197983 - KOIKE; Tatsuki ;   et al.
2017-07-13
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20170145031 - KOIKE; Tatsuki ;   et al.
2017-05-25
Heterocyclic compounds having cholesterol 24-hydroxylase activity
Grant 9,643,957 - Koike , et al. May 9, 2
2017-05-09
Radiolabeled Compounds
App 20170114042 - KOIKE; Tatsuki ;   et al.
2017-04-27
4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitors
Grant 9,624,170 - Koike , et al. April 18, 2
2017-04-18
Heterocyclic compound
Grant 9,624,184 - Koike , et al. April 18, 2
2017-04-18
Heterocyclic compound
Grant 9,598,398 - Koike , et al. March 21, 2
2017-03-21
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 9,586,930 - Koike , et al. March 7, 2
2017-03-07
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20160326136 - KOIKE; Tatsuki ;   et al.
2016-11-10
4-(piperrazin-1-yl)-pyrrolidin-2-one Compounds As Monoacylglycerol Lipase (magl) Inhibitors
App 20160318864 - KOIKE; Tatsuki ;   et al.
2016-11-03
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 9,440,990 - Koike , et al. September 13, 2
2016-09-13
Heterocyclic compound
Grant 9,296,746 - Koike , et al. March 29, 2
2016-03-29
Heterocyclic Compound
App 20160052897 - KOIKE; Tatsuki ;   et al.
2016-02-25
Heterocyclic Compound
App 20160024049 - KOIKE; Tatsuki ;   et al.
2016-01-28
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20150376205 - KOIKE; Tatsuki ;   et al.
2015-12-31
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
Grant 9,193,709 - Koike , et al. November 24, 2
2015-11-24
Heterocyclic Compound
App 20150315209 - KOIKE; Tatsuki ;   et al.
2015-11-05
Heterocyclic Compound
App 20150266872 - Koike; Tatsuki ;   et al.
2015-09-24
Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
Grant 8,901,309 - Koike , et al. December 2, 2
2014-12-02
Heterocyclic Compound And Use Thereof
App 20140350260 - KOIKE; Tatsuki ;   et al.
2014-11-27
Tricyclic compound and pharmaceutical use thereof
Grant 8,895,591 - Uchikawa , et al. November 25, 2
2014-11-25
Heterocyclic compounds
Grant 8,871,766 - Koike , et al. October 28, 2
2014-10-28
Heterocyclic compounds
Grant 8,865,717 - Koike , et al. October 21, 2
2014-10-21
Heterocyclic compound and use thereof
Grant 8,822,699 - Koike , et al. September 2, 2
2014-09-02
1-arylcarbonyl-4-oxy-piperidine Compounds Useful For The Treatment Of Neurodegenerative Diseases
App 20140228373 - Koike; Tatsuki ;   et al.
2014-08-14
Heterocyclic Compounds
App 20140088146 - KOIKE; Tatsuki ;   et al.
2014-03-27
Heterocyclic Compounds
App 20140088118 - KOIKE; Tatsuki ;   et al.
2014-03-27
Heterocyclic compounds
Grant 8,648,079 - Koike , et al. February 11, 2
2014-02-11
Tricyclic Compound And Pharmaceutical Use Thereof
App 20140011849 - UCHIKAWA; Osamu ;   et al.
2014-01-09
Tricyclic compound and pharmaceutical use thereof
Grant 8,552,037 - Uchikawa , et al. October 8, 2
2013-10-08
Fused Triazoles For The Treatment Or Prophylaxis Of Mild Cognitive Impairment
App 20130178497 - Koike; Tatsuki ;   et al.
2013-07-11
Heterocyclic Compounds
App 20130090341 - KOIKE; Tatsuki ;   et al.
2013-04-11
Tricyclic Compound And Pharmaceutical Use Thereof
App 20130079374 - UCHIKAWA; Osamu ;   et al.
2013-03-28
Tricyclic compound and pharmaceutical use thereof
Grant 8,349,879 - Uchikawa , et al. January 8, 2
2013-01-08
Tricyclic compound and medical use thereof
Grant 8,273,761 - Uchikawa , et al. September 25, 2
2012-09-25
Tricyclic compound and pharmaceutical use thereof
Grant 8,247,429 - Uchikawa , et al. August 21, 2
2012-08-21
Tricyclic compound and pharmaceutical use thereof
Grant 8,236,837 - Uchikawa , et al. August 7, 2
2012-08-07
Heterocyclic Compound And Use Thereof
App 20120142672 - Koike; Tatsuki ;   et al.
2012-06-07
Heterocyclic Compound And Use Thereof
App 20120059030 - KOIKE; Tatsuki ;   et al.
2012-03-08
Bicyclic compound and pharmaceutical use thereof
Grant 8,110,585 - Koike , et al. February 7, 2
2012-02-07
Tricyclic compound and pharmaceutical use thereof
Grant 8,030,337 - Uchikawa , et al. October 4, 2
2011-10-04
Tricyclic Compound And Pharmaceutical Use Thereof
App 20110196003 - Uchikawa; Osamu ;   et al.
2011-08-11
Tricyclic Compound And Pharmaceutical Use Thereof
App 20110190361 - UCHIKAWA; Osamu ;   et al.
2011-08-04
Bicyclic Compound And Pharmaceutical Use Thereof
App 20100130538 - Koike; Tatsuki ;   et al.
2010-05-27
Tricyclic Compound And Medical Use Thereof
App 20100029707 - Uchikawa; Osamu ;   et al.
2010-02-04
Tricyclic Compound And Pharmaceutical Use Thereof
App 20100010038 - Uchikawa; Osamu ;   et al.
2010-01-14
Tricyclic Compound And Pharmaceutical Use Thereof
App 20090182023 - Uchikawa; Osamu ;   et al.
2009-07-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed